Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma.
Clinical trial NCT07739654 · RECRUITING
Trial details
- NCT number
- NCT07739654
- Sponsor
- King Edward Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2027-05-20
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.